EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring

Alejandro G Schijman iD, Colin Forsyth, Alba Abras, Igor C Almeida, Julio Alonso-Padilla, Cristina Alonso-Vega, Cristina Ballart-Ferrer, Margarita Bisio, Constança Britto, Eric Dumonteil, María Flores-Chavez, Montserrat Gallego und 10 weitere

PLOS Neglected Tropical Diseases · 09.07.2026 · 20 (7) · e0014452

DOI: 10.1371/journal.pntd.0014452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 09.07.2026. Verfasst von Alejandro G Schijman und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biologia Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Tor…. Hauptthemen laut MEDLINE: Chagas Disease, Drug Monitoring, Real-Time Polymerase Chain Reaction, Trypanocidal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas disease remains a neglected global health problem with major diagnostic and therapeutic challenges. Progression from acute to chronic infection may lead to cardiac or digestive complications in approximately 20–40% of patients, depending on geographic region and duration of follow-up. However, reliable prognostic markers are still lacking, underscoring the importance of early diagnosis and timely treatment. For over 40 years, therapy has relied on benznidazole and nifurtimox, effective in acute but inconsistent in chronic disease, with frequent adverse effects undermining adherence. Current research is testing shorter regimens, lower doses, and novel compounds. Their evaluation is constrained by the lack of standardized biomarkers of treatment response. Serology requires decades to confirm treatment effect, whereas quantitative PCR (qPCR) enables earlier detection of therapeutic failure. However, heterogeneity of qPCR protocols hampers cross-trial comparisons and meta-analyses. To resolve these limitations, the Drugs for Neglected Diseases initiative convened experts to build consensus on qPCR application in clinical trials aiming to define a target product profile supporting drug development and regulatory approval.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chagas DiseaseDrug MonitoringReal-Time Polymerase Chain ReactionTrypanocidal AgentsTrypanosoma cruziHumansNifurtimoxNitroimidazoles

Substanzen

benzonidazoleNifurtimoxNitroimidazolesTrypanocidal Agents

Autor:innen und Institutionen

  • Laboratorio de Biologia Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Héctor Torres" (INGEBI-CONICET), Buenos Aires, Argentina.
  • Chagas Program, Drugs for Neglected Diseases Initiative (DNDi) LATAM, Rio de Janeiro, Brazil.
  • Departamento de Biología, Universidad de Girona, Girona, Spain.
  • Department of Biological Sciences, University of Texas "El Paso", El Paso, Texas, United States of America.
  • Instituto de Salud Global de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Alejandro G Schijman, María-Jesus Pinazo

Zitieren

APA

Schijman, A. G., Forsyth, C., Abras, A., Almeida, I. C., Alonso-Padilla, J., Alonso-Vega, C., Ballart-Ferrer, C., Bisio, M., Britto, C., Dumonteil, E., Flores-Chavez, M., Gallego, M., Herrera-Bernal, C. P., Lopez-Albizu, C., Moreira, O. C., Muñoz-Calderon, A., Pinto, L., Ramirez, J. C., Scandale, I., …, & Pinazo, M. J. (2026). Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring. PLOS Neglected Tropical Diseases, 20(7), e0014452. https://doi.org/10.1371/journal.pntd.0014452

Vancouver

Schijman AG, Forsyth C, Abras A, Almeida IC, Alonso-Padilla J, Alonso-Vega C, et al. Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring. PLOS Neglected Tropical Diseases. 2026;20(7):e0014452. doi:10.1371/journal.pntd.0014452

BibTeX
@article{Schijman2026,
  author = {Schijman, Alejandro G and Forsyth, Colin and Abras, Alba and Almeida, Igor C and Alonso-Padilla, Julio and Alonso-Vega, Cristina and Ballart-Ferrer, Cristina and Bisio, Margarita and Britto, Constança and Dumonteil, Eric and Flores-Chavez, María and Gallego, Montserrat and Herrera-Bernal, Claudia P and Lopez-Albizu, Constanza and Moreira, Otacilio C and Muñoz-Calderon, Arturo and Pinto, Lilian and Ramirez, Juan C and Scandale, Ivan and Shikanai-Yasuda, María A and Sosa-Estani, Sergio and Pinazo, María-Jesus},
  title = {Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {7},
  pages = {e0014452},
  doi = {10.1371/journal.pntd.0014452}
}
Kostenlos starten →